The Race Is On to Create Rapid Covid-19 Tests

As states begin to reopen, it is important to realize that coronavirus has not gotten less infectious. COVID-19 testing is still not accessible to every individual across the country therefore counties and states across the U.S. must take this into account when considering the effects of reopening businesses. This is where rapid diagnostics technology plays of utmost importance.

Omnivis’s rapid testing diagnostic for cholera is now being researched to adapt the technology for COVID-19 testing. OmniVis CEO, Katherine Clayton, discusses the importance of rapid testing and the nuances in this Wall Street Journal (WSJ) article about at-home diagnostics for infectious disease.